1. Cassina, Matteo, Rigon, Chiara, Casarin, Alberto, Salviati, Leonardo, Clementi, Maurizio. 2015. FBXO28 is a critical gene of the 1q41q42 microdeletion syndrome. In American journal of medical genetics. Part A, 167, 1418-20. doi:10.1002/ajmg.a.37033. https://pubmed.ncbi.nlm.nih.gov/25900767/
2. Qiao, Xinran, Lin, Jingyu, Shen, Jiajia, Li, Pengyu, Wang, Zhen. 2023. FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation. In Oncogene, 42, 2878-2891. doi:10.1038/s41388-023-02809-0. https://pubmed.ncbi.nlm.nih.gov/37596321/
3. Au, P Y Billie, Argiropoulos, Bob, Parboosingh, Jillian S, Micheil Innes, A. 2013. Refinement of the critical region of 1q41q42 microdeletion syndrome identifies FBXO28 as a candidate causative gene for intellectual disability and seizures. In American journal of medical genetics. Part A, 164A, 441-8. doi:10.1002/ajmg.a.36320. https://pubmed.ncbi.nlm.nih.gov/24357076/
4. Sirianansopa, Kantisa, Amin, Reshma. 2024. Acetazolamide as a therapeutic alternative for central sleep apnea in pediatric patient with FBXO28 gene mutation: A case report and review of literature. In Sleep medicine, 124, 479-482. doi:10.1016/j.sleep.2024.10.023. https://pubmed.ncbi.nlm.nih.gov/39432981/
5. Liu, Songbai, Liu, Peng, Zhu, Changhao, Wang, Xing, Pan, Yaozhen. 2023. FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. In Aging, 15, 5381-5398. doi:10.18632/aging.204780. https://pubmed.ncbi.nlm.nih.gov/37348029/
6. Kratz, Anne-Sophie, Richter, Kai T, Schlosser, Yvonne T, Delecluse, Henri-Jacques, Hoffmann, Ingrid. 2016. Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation. In Cell cycle (Georgetown, Tex.), 15, 3419-3431. doi:10.1080/15384101.2016.1246093. https://pubmed.ncbi.nlm.nih.gov/27754753/
7. Phillips, Emma, Balss, Jörg, Bethke, Frederic, Fendt, Sarah-Maria, Goidts, Violaine. 2022. PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma. In Oncogenesis, 11, 57. doi:10.1038/s41389-022-00433-3. https://pubmed.ncbi.nlm.nih.gov/36115843/
8. Balak, Chris, Belnap, Newell, Ramsey, Keri, Huentelman, Matt, Narayanan, Vinodh. . A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype. In American journal of medical genetics. Part A, 176, 1549-1558. doi:10.1002/ajmg.a.38712. https://pubmed.ncbi.nlm.nih.gov/30160831/
9. Bi, Xin, Mulhern, Maureen S, Spiegel, Erica, Bain, Jennifer M, Liao, Jun. 2023. 3' UTR Deletion of FBXO28 in a Patient with Brain Abnormalities and Developmental Delay. In Genes, 14, . doi:10.3390/genes14091687. https://pubmed.ncbi.nlm.nih.gov/37761828/